Share This Profile
Share this profile on Facebook.
Link to this profile on LinkedIn.
Tweet this profile on Twitter.
Email a link to this profile.
See other services through which you can share this profile.
This profile was last updated on 6/8/14  and contains information from public web pages.

Dr. Cheryl Lee Barton

Wrong Dr. Cheryl Lee Barton?

Co Founder

Phone: +44 **** ******  HQ Phone
PHARMAVISION Companies
Post Office Lane North Mundham
Chichester, West Sussex PO20 1JY
United Kingdom

Company Description: PharmaVision offers a comprehensive choice of high quality, insightful reports which identify key trends, future innovations, and growth opportunities. Our reports...   more
Background

Employment History

Education

  • Ph.D.
  • doctorate
    Queen's University Belfast
38 Total References
Web References
Pharmavision | Our Writers
pharmavision.co.uk, 8 June 2014 [cached]
Dr Cheryl Lee Barton (Co Founder)
...
Dr Cheryl Lee Barton
Dr Cheryl L Barton is an independent consultant with over 18 years' research and business analysis experience. Following her senior research positions in academia and seven years with Merck, in which she was responsible for a variety of CNS research projects. Dr Barton joined Dutch investment bank ABN Amro NV as a senior equity analyst to provide coverage on pan-European companies, and assessed the potential impact of new drug development on European Stocks. In 2002, Dr Barton founded PharmaVision to provide independent, tailor-made, life science and consumer health research to pharmaceutical companies, competitive intelligence specialists, investment institutions, and healthcare communication agencies.
Pharmavision | Expert Commentary
pharmavision.co.uk, 1 May 2011 [cached]
Cheryl Barton, a biochemist who runs the consultancy PharmaVision in West Sussex, UK, says this outsourcing represents a sea change from the old way of doing things. "When I worked at Merck years ago, it was one of those companies that didn't outsource anything at all," she says.
...
"The market is demanding controlled release technology," says Cheryl Barton, director of the Chichester, UK - based biomedical consultancy Pharmavision. She notes that patients like the convenience of once-a-day pills as opposed to having to remember to take multiple doses morning, noon and night.
According to a 2009 Pharmavision report, medications using controlled release technology generate annual sales in excess of $20 billion. And although the majority of such sales currently derive from pill formulations, injectables are on the rise, Barton says.
...
"There's a price to be paid for the convenience of those products," says Barton. This, she notes, has resulted in uneven adoption of time-release medications from country to country. "One of the biggest markets for this has been the US," she explains, but European countries with nationalized health systems seem less keen to pay for such medications."
...
With concern growing over the side effects of RNAi-based treatments, firms must now "conclusively prove the mechanism of action of their products", says PharmaVision consultant Cheryl Barton.
...
"I believe they have up to 90% of the patents," says analyst/consultant Cheryl Barton.
...
Many of them are launching initiatives that combine in vitro diagnostics with therapeutic solutions in one procedure, according to Dr Cheryl Barton, founder of U.K. consultant firm PharmaVision.
Targeted carrier systems represented about half of the $6.5 billion market for advanced drug delivery in 2006, reported Barton.
Dr Cheryl L Barton is an ...
www.espicom.com, 19 June 2013 [cached]
Dr Cheryl L Barton is an independent consultant with over 16 years of research and business analysis experience. Following her research positions in academia and seven years with Merck, Dr Barton joined investment bank ABN Amro NV as a senior equity analyst to provide coverage on pan-European companies, and assess the potential impact of new drug development on European Stocks. In 2002, Dr Barton founded PharmaVision to provide independent, tailor-made, life science and consumer health research. For Espicom she has authored a number of business and strategy titles.
Pharmavision - Our Writers
www.pharmavision.co.uk, 14 June 2011 [cached]
Dr Cheryl Lee Barton (Co Founder)
...
Dr Cheryl Lee Barton (Co Founder)
Pharmavision | The Company
www.pharmavision.co.uk, 4 Jan 2007 [cached]
PharmaVision was created by Dr Cheryl Lee Barton in 2002 to provide high quality, due diligence research and independent, tailor made life science reports to pharmaceutical companies, competitive intelligence specialists, investment institutions and healthcare communication agencies.
Other People with the name "Barton":
Other ZoomInfo Searches
Accelerate your business with the industry's most comprehensive profiles on business people and companies.
Find business contacts by city, industry and title. Our B2B directory has just-verified and in-depth profiles, plus the market's top tools for searching, targeting and tracking.
Atlanta | Boston | Chicago | Houston | Los Angeles | New York
Browse ZoomInfo's business people directory. Our professional profiles include verified contact information, biography, work history, affiliations and more.
Browse ZoomInfo's company directory. Our company profiles include corporate background information, detailed descriptions, and links to comprehensive employee profiles with verified contact information.